Table 1.

Correlation within HAS2-AS1 level and clinicopathological feature of NSCLC patients

	No	HAS2-AS1		p
		Low No=14	High No=16
Gender				0.531
Male	17	8	9
Female	13	6	7
Age (years)				0.403
≥ 65	16	6	10
< 65	14	8	6
Primary location				0.712
Left	16	7	9
Right	14	7	7
Tumor size				0.075
≥ 4 cm	16	5	11
< 4 cm	14	9	5
Differentiation				0.001*
Well, moderate	11	8	3
Poor	19	6	13
TNM				0.012*
I-II	12	8	4
III/IV	18	6	12
Lymphonode metastasis				0.568
No	15	8	7
Yes	15	6	9

^*P < 0.05 represents statistical difference.